期刊文献+

奥硝唑和培氟沙星不同配伍对牙周病原菌体外抗菌作用 被引量:8

Antibacterial Activities of Different Proportions of Ornidazole and Pefloxacin Against Periodontal Pathogen in Vitro.
下载PDF
导出
摘要 目的:了解奥硝唑和培氟沙星不同比例配伍对牙周病原菌体外抑菌效果。方法:1)奥硝唑和培氟沙星各自分为6水平,测量两种药物不同比例水平混合后对牙龈卟啉单胞菌,具核梭杆菌,中间普氏菌,消化链球菌标准菌株的抑菌指标变化,通过统计检验找出奥硝唑和培氟沙星不同配伍抑菌指标的无差别比例范围,并找出合适比例。2)检测两种药物以及其合适的比例对厌氧菌标准菌株和42株临床分离的非厌氧菌的MIC和MIC50。结果:牙龈卟啉单胞菌,具核梭杆菌,中间普氏菌,消化链球菌对奥硝唑和培氟沙星不同配伍所测指标的无差别范围分别是6:1—1:2、6:1—2:3、6:1—2:3、6:1—1:1。结论:两种药物混合对细菌的抑菌效果以2:3为佳,但有待进一步动物实验和临床验证。 Objective: To understand antibacterial activities of different proportions of Omidasole and Pefloxacin against periodontal pathogen in vitro. Methods: 1 ) Omidasole and Pefloxacin are divided to six levels, in order to measure the changes of antihlastic indexes of different proportions of Omidazole and Pefloxacin against Pg ,Fn,Pi,and Peptostreptoeoecus spp. Statistical test is used to seek the indistinctive ranges of antibacterial activities of Omidazole and Pefloxacin against those four kinds of typical periodontal pathogens, and to find the suitable proportion. 2 ) To measure MIC and MIC50 of Omidazole and Pefloxacin and the most suitable proportion against all bacterias. Results: The ranges of indistinctive antibacterial activities for four kinds of typical periodontal pathogens are 6:1 ~ 1: 2,6: 1 ~ 2: 3,6: 1 ~ 2:3 and 6:1 ~ 1 : 1. Conclusion: The proportion of 2:3 can inhibit anaerobic bacterium and aerobic bacteria effectively, however, animal experiment and clinical verification are needed.
出处 《口腔医学研究》 CAS CSCD 2006年第2期162-165,共4页 Journal of Oral Science Research
关键词 奥硝唑 培氟沙星 抗菌活性 Ornidazole Pefloxaein Antibacterial activities
  • 相关文献

参考文献10

  • 1刘学聪,边百川,张玉.奥硝唑糊剂治疗牙周炎的近期疗效观察[J].现代中西医结合杂志,2004,13(15):2019-2019. 被引量:12
  • 2李从荣,金正江,詹,丁俊清,李艳,彭少华.奥硝唑治疗口腔厌氧菌感染的临床与实验研究[J].中华医院感染学杂志,2004,14(3):325-327. 被引量:40
  • 3Cennet Celik.In vitro activities of tinidazole and metronidazole against clostridium diffieile,prevotellabivia and bacteroides fragilis[J].Anaerobe,2005,4(17):101-103
  • 4于守汎.培氟沙星在目前抗菌疗法中的地位[J].国外医药(抗生素分册),2002,23(4):179-181. 被引量:7
  • 5周学东,肖晓蓉.口腔微生物学[M].四川大学出版社,2001,4(15):390-407
  • 6Socransky S,Haffajee A.Evidence of aetiology:a historical perspective[J].Periodontol,2000,1994(5):7-10
  • 7Zambon JJ.Periodontal diseases:microbial factors[J].An Periodontol,1996,1(12):879-883
  • 8Tyrrell KL.In vitro activity of oritavancin (LY333328),vancomycin,clindamycin,and metronidazole against Clostridium perfringens,Propionibacterium acnes,and anaerobic Gram-positive cocci[J].Anaerobe,2005,11(2):93-95
  • 9Kamma JJ,Nakou M,Mitsis FJ.The clinical and microbiological effects of systemic ornidazole in sites with and without subgingival debridement in early-onset periodontitis patients[J].Periodonto,2000,71(12):1 862-1 865
  • 10Sydney M.Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota[J].Anaerobe,2004,10(5):255-259

二级参考文献5

  • 1王仁飞,陈莉丽,倪可夫,严杰,朱仲珍,来永胜.替硝唑治疗成人牙周炎的疗效评价[J].中华口腔医学杂志,1996,31(5):303-306. 被引量:78
  • 2Richle VR, Sctoler HJ, Angehrn P, et al.Grundlagen der chemotherapie von trichomoniasis und amoebiasis mit ornidazole[J].Arzneim Forsch/Drug Res, 1978, 28(1): 612-625.
  • 3Wust J.Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods[J].Antimicrob Agents Chemother, 1977, 11(4): 631-637.
  • 4曹彩方.牙周病学[M].北京:人民卫生出版社,2001.84-95.
  • 5许淑珍,马纪平.临床厌氧菌检验应与时俱进[J].中华检验医学杂志,2002,25(3):135-136. 被引量:34

共引文献49

同被引文献54

  • 1刘娟,肖丽英,李伟,丁一,张萍,袁明龙.可吸收聚乳酸-替硝唑抗菌缓释剂体外药物释放效果的测定[J].华西口腔医学杂志,2005,23(3):237-239. 被引量:3
  • 2蒋艳,刘鲁川,李楠,段延华.奥硝唑牙栓的制备及质量控制[J].第三军医大学学报,2006,28(9):990-991. 被引量:12
  • 3刘鲁川,蒋艳,孟德胜,段延华,李楠.复方奥硝唑甲磺酸培氟沙星缓释牙栓的研制及质量控制[J].口腔医学研究,2007,23(1):10-13. 被引量:3
  • 4Valenza G, Veihelmann S, Peplies J, et al. Microbial changes in periodontitis successfully treated by mechanical plaque removal and systemic amoxicillin and metronidazole [ J ] .Int J Med Microbiol, 2009, 299 (6) :427 - 438.
  • 5Baumstark-Khan C, Rabbow E, Rettberg P, et al. The combined bacterial Lux-Fluoro test for the detection and quantification of genotoxic and cytotoxic agents in surface water: results from the " Technical Workshop on Genotoxicity Biosensing" [J]. Aquatic Toxicol, 2007, 85(3):209-218.
  • 6Mouchet F, Gauthier L, Mailhes C, et al. Biomonitoring of the genotoxic potential of aqueous extracts of soils and bottom ash resuiting from municipal solid waste incineration, using the comet and micronucleus tests on amphibian ( Xenopus laevis) larvae and bacterial assays (Mutatox and Ames tests) [ J ]. Sci Total Environ, 2006, 355 ( 1 - 3 ) :232 - 246.
  • 7Miyazawa M, Hisama M. Antimutagcnic activity of flavonoids from Chrysanthemum morifolium [ J ]. Biosci Biotech Bioch, 2003,67 (10) :2091.
  • 8Josephy PD, Weadge J J, Meissner J, et al. Ames test evaluation of two commercially available zero-valent nickel compounds [ J] Murat Res/Gen Toxicology and Environmental Mutagenesis, 2008, 654(1): 64-68.
  • 9Tervit C, Paquette J, Tormeck D, et al. Proportion of healed teeth with apical periodontitis medicated with two percent chlorhexidine gluconatc liquid: A case-serles study [ J ] . J End, 2009, 35(9) :1182-1185.
  • 10Matsushima T, Hayashi M, Matsuoka A, et al. Validation study of the in vitro mieronucleus test in a Chinese hamster lung cell line (CHL/IU) [J]. Mutagenes is, 1999, 14(6) :569 -580.

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部